RIGHT REMEDIES
LIVE

Serial Number

87841386

Owner

Strive Pharmaceuticals Inc.

Attorney

Stuart M. Goldstein

First Use Date

Mar 22, 2016

Filing Date

Mar 20, 2018

Add to watchlist:

No watchlists yet
View on USPTO

RIGHT REMEDIES Trademark

Serial Number: 87841386 • Registration: 5605926

RIGHT REMEDIES is a trademark filed by Strive Pharmaceuticals Inc. on March 20, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Strive Pharmaceuticals Inc. (12 trademarks)

19 Lexington Ave.
East Brunswick, NJ 08816

Entity Type: 03

Trademark Details

Filing Date

March 20, 2018

Registration Date

November 13, 2018

First Use Anywhere

March 22, 2016

First Use in Commerce

March 16, 2018

Published for Opposition

August 28, 2018

Goods & Services

Allergy medications; Allergy relief medication; Amino acid preparations for medical purposes; Amino acids for nutritional purposes; Anesthetic for surgical purposes; Anesthetics for non-surgical use; Anesthetics for surgical and non-surgical use; Antibiotic creams; Antibiotic handwash; Antibiotic ointments; Antibiotic preparations; Antibiotic tablets; Antibiotics; Antifungal creams for medical use; Antihistamines; Calcium supplements; Contraceptive foams; Contraceptive preparations; Contraceptive sponges; Dental amalgams; Dental impression materials; Dental polish; Dental tablets for disclosing plaque and tartar on the teeth; Dental waxes; Deodorizing products, namely, all-purpose deodorizer preparations for household, commercial and industrial use; Diagnostic agents, preparations and substances for medical purposes; Diagnostic preparations for medical purposes; Diarrhea medication; Diet capsules; Diet pills; Dietary and nutritional supplements; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary supplements consisting primarily of calcium; Dietary supplements for human consumption; Electrolyte drinks for medical purposes; Electrolyte replacement solutions; Enzyme dietary supplements; Enzymes for medical purposes; Medicated eye washes; Medicated eye-washes; Fungicides for medical use; Hair growth stimulants; Hemorrhoid treatment preparations; Hemorrhoidal ointments; Herbal supplements; Herbal supplements for sleeping problems; Material for repairing teeth and for dental crowns and bridges; Medical lubricant, namely, vaginal lubricants; Medicated anti-cavity dental rinses; Medicated dental rinses; Medicated diaper rash ointments and lotions; Medicated hair care preparations; Medicated lotions for treating dermatological conditions; Medicines for dental purposes; Migraine treatment preparations; Mixed antibiotic preparations; Molding wax for dental use; Nail fungus treatment preparations; Nutritional supplements consisting primarily of calcium; Oral contraceptives; Orthodontic alginate for dental impressions; Pain relief medication; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceuticals, namely, anti-infectives; Room deodorants; Sleeping pills/tablets; Topical anesthetics; Vaginal preparations, namely, antifungals

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Mar 10, 2025 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Mar 10, 2025 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 10, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
Nov 7, 2024 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 13, 2023 REM1
REGISTERED-PRINCIPAL REGISTER
Nov 13, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 28, 2018 NPUB
PUBLISHED FOR OPPOSITION
Aug 28, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 8, 2018 NONP
ASSIGNED TO LIE
Jul 23, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 7, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 7, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 7, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 7, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 7, 2018 CNEA
ASSIGNED TO EXAMINER
Jun 30, 2018 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 27, 2018 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 26, 2018 NWOS
NEW APPLICATION ENTERED
Mar 23, 2018 NWAP